Hong Kong stocks unusual | Fosun Pharma (02696.HK) surged more than 4% in the afternoon. Recently, the Phase I clinical trial of Hansinex in Japan for the first-line treatment of small cell lung cancer has completed enrollment.
Caijing App learned that Fuhong Hanlin (02696.HK) rose over 4% in the afternoon, with a 3.19% increase as of the time of publication, reaching 69.65 Hong Kong dollars, with a trading volume of 37.252 million Hong Kong dollars.
Latest
